Anti-SMN antibody-positive patients with RMDs exhibit a higher prevalence of ILD, PAH, myositis, and SSc-related symptoms compared with anti-SMN antibody-negative patients [8, 9, 26]. The gene discussed is SMN1; the disease is interstitial lung disease.